Back D - Search Results

1

Steady-state pharmacokinetics of lopinavir plus ritonavir when administered under different meal conditions in HIV-infected Ugandan adults.

Lamorde M, Byakika-Kibwika P, Boffito M, Nabukeera L, Mayito J, Ogwal-Okeng J, Tjia J, Back D, Khoo S, Ryan M, Merry C. Lamorde M, et al. Among authors: back d. J Acquir Immune Defic Syndr. 2012 Jul 1;60(3):295-8. doi: 10.1097/QAI.0b013e3182567a35. J Acquir Immune Defic Syndr. 2012. PMID: 22481601 Free PMC article. Clinical Trial.

2

Improved tolerability of ritonavir derived from pharmacokinetic principles.

Merry C, Barry M, Gibbons S, Mulcahy F, Back D. Merry C, et al. Among authors: back d. Br J Clin Pharmacol. 1996 Dec;42(6):787. doi: 10.1046/j.1365-2125.1996.d01-3339.x. Br J Clin Pharmacol. 1996. PMID: 8971438 Free PMC article. Clinical Trial. No abstract available.

3

Saquinavir interaction with midazolam: pharmacokinetic considerations when prescribing protease inhibitors for patients with HIV disease.

Merry C, Mulcahy F, Barry M, Gibbons S, Back D. Merry C, et al. Among authors: back d. AIDS. 1997 Feb;11(2):268-9. AIDS. 1997. PMID: 9030388 No abstract available.

4

Nelfinavir and nevirapine interaction?

Mulcahy F, Barry M, Merry C, Back D. Mulcahy F, et al. Among authors: back d. AIDS. 1998 Dec 3;12(17):2361. AIDS. 1998. PMID: 9863887 No abstract available.

5

Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infection.

Barry M, Mulcahy F, Merry C, Gibbons S, Back D. Barry M, et al. Among authors: back d. Clin Pharmacokinet. 1999 Apr;36(4):289-304. doi: 10.2165/00003088-199936040-00004. Clin Pharmacokinet. 1999. PMID: 10320951 Review.

6

Current uses and future hopes for clinical pharmacology in the management of HIV infection.

Back D, Khoo S, Maher B, Gibbons S. Back D, et al. HIV Med. 2000 Jul;1 Suppl 2:12-7. doi: 10.1046/j.1468-1293.2000.00001.x. HIV Med. 2000. PMID: 11737367 Free article. Review. No abstract available.

7

Undefined duration of opiate withdrawal induced by efavirenz in drug users with HIV infection and undergoing chronic methadone treatment.

Boffito M, Rossati A, Reynolds HE, Hoggard PG, Back DJ, Di Perri G. Boffito M, et al. AIDS Res Hum Retroviruses. 2002 Mar 20;18(5):341-2. doi: 10.1089/088922202753519115. AIDS Res Hum Retroviruses. 2002. PMID: 11897035 No abstract available.

8

Therapeutic drug monitoring in HIV infection: current status and future directions.

Back D, Gatti G, Fletcher C, Garaffo R, Haubrich R, Hoetelmans R, Kurowski M, Luber A, Merry C, Perno CF. Back D, et al. AIDS. 2002 Mar;16 Suppl 1:S5-37. doi: 10.1097/00002030-200203001-00002. AIDS. 2002. PMID: 12035820 Review.

9

Alpha 1-acid glycoprotein levels in human immunodeficiency virus-infected subjects on antiretroviral regimens.

Boffito M, Sciole K, Raiteri R, Bonora S, Hoggard PG, Back DJ, Di Perri G. Boffito M, et al. Drug Metab Dispos. 2002 Jul;30(7):859-60. doi: 10.1124/dmd.30.7.859. Drug Metab Dispos. 2002. PMID: 12132432 No abstract available.

10

Pharmacokinetic evaluation of indinavir and indinavir/ritonavir-containing antiretroviral regimens in a clinical setting.

Boffito M, Bonora S, Raiteri R, Reynolds HE, Hoggard PG, Sinicco A, Back DJ, Di Perri G. Boffito M, et al. Ther Drug Monit. 2002 Aug;24(4):574-6. doi: 10.1097/00007691-200208000-00021. Ther Drug Monit. 2002. PMID: 12142647 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

815 results

Search Page

Filters